AI Stock Memo: CLB - Core Laboratories - RankAlpha

CLB

Rating sellAI Memo

Core Laboratories

As of 2026-02-05/Confidence medium

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-02-05 • Model: RankAlpha Sentiment AI

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Action

sell

Confidence

medium

Horizon

—

Key catalyst

Q4 / FY2025 Earnings Release (assumed) • 2026-05-06

Expected move: +25%

Biggest risk

Persistent weak E&P spending, contract pressure, or cash-flow deterioration forces multiple contraction and potential dividend adjustments, driving downside toward the analyst low (bear target).

Invalidation

Break below $12 or thesis failure.

What would change my mind?

Stronger upstream capex and sustained demand for reservoir services drive revenue and multiple expansion, supporting upside toward the analyst high (bull target).

Research note

Recommendation

sell

Confidence

medium

As of

2026-02-05

Base target

$17

p=60%

Bull target

$22

p=20%

Bear target

$12

p=20%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

Dividend / cash-return sustainability review
Industry capex recovery / long-term E&P activity rebound
Stronger upstream capex and sustained demand for reservoir services drive revenue and multiple expansion, supporting upside toward the analyst high (bull target).

BearKey bullets

Contract pricing pressure on specialized services
Dividend cut or payout suspension
Prolonged E&P capital spending decline

WatchKey bullets

Q4 / FY2025 Earnings Release (assumed)

Summary

High-level snapshot

Recommendation

sell

Model confidence

medium

Timeframe

Asset

Equity

Trigger

Base case: $17 (p=60%)

Bull/Bear spread: +62% / -15%

Vs latest close: Bull +62% · Base +25% · Bear -15%

Scenario probabilities

Bull Target: $22 (p=20%)Base Target: $17 (p=60%)Bear Target: $12 (p=20%)

Commentary

Aggregated analyst targets show a median ($17.00) below the anchor (19.61) and a wide spread, signaling cautious Street sentiment. Recent positive earnings mentions provide episodic upside but investor focus remains on capex visibility and cash-flow execution; overall tone is cautiously negative-to-neutral, consistent with a sell bias.

As of 2026-02-05 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

Stronger upstream capex and sustained demand for reservoir services drive revenue and multiple expansion, supporting upside toward the analyst high (bull target).

Bear Case

Persistent weak E&P spending, contract pressure, or cash-flow deterioration forces multiple contraction and potential dividend adjustments, driving downside toward the analyst low (bear target).

Drivers

Scannable catalysts and supporting factors

Dividend / cash-return sustainability review
Industry capex recovery / long-term E&P activity rebound

Human Analyst Targets

External snippets for comparison only; verify at source.

Unverified externalLast fetched 2026-02-05Source quality: external scrape

External snippets are unverified; treat as directional signals only. Always confirm with the original provider.

Inline RA est

Provider

serper

Median (USD)

$17.00

Range (USD)

$11.50 - $22.00

Count

Query: Core Laboratories Inc Common (CLB) analyst consensus price target high low average

Core Laboratories Inc. (CLB) Stock Price, News, Quote & History
Search result #1
Core Laboratories (CLB) Beats Q4 Earnings and Revenue Estimates. Zacks • 13h ... Analyst Insights: CLB. View More. Analyst Price Targets. 11.50 Low. 15.83 ...
Open source
Core Laboratories (CLB) Price Targets - Zacks Investment Research
Search result #2
The forecasts range from a low of $11.50 to a high of $22.00. The average price target represents a decline of 14.71% from the last closing price of $19.64.
Extracted: $11.50, $22.00, $19.64Open source
Core Laboratories Inc.: Target Price Consensus and Analysts ...
Search result #3
Analysts' Consensus ; Mean consensus. HOLD ; Number of Analysts. 3 ; Last Close Price. 19.00USD ; Average target price. 14.50USD ; Spread / Average Target. -23.68%.
Extracted: $19.00, $14.50Open source
Core Laboratories Stock Price Today | NYSE: CLB Live - Investing.com
Search result #4
The average 12-month price target for Core Laboratories is USD15.83, with a high estimate of USD22 and a low estimate of USD11.5. 1 analysts recommend buying ...
Extracted: $15.83, $22.00, $11.50Open source
CLB | Core Laboratories Inc. Analyst Estimates & Ratings – WSJ
Search result #5
Stock Price Target CLB. High, $22.00. Median, $14.00. Low, $11.50. Average, $15.83. Current Price, $19.48. Related Links: Options · Overview · Research & ...
Extracted: $22.00, $14.00, $11.50, $15.83, $19.48Open source
Core Laboratories: CLB Stock Price Quote & News - Robinhood
Search result #6
With a market cap of 910.17M, Core Laboratories(CLB) trades at $19.54. The stock has a price-to-earnings ratio of 28.29 and currently yields dividends of 20.5%.
Extracted: $19.54Open source

Scenarios

Bull Target (Scenario probability)

$22 / p=20% prob

Base Target (Scenario probability)

$17 / p=60% prob

Bear Target (Scenario probability)

$12 / p=20% prob

Price $14 as of 2026-06-02

Nearest Scenario: Bear (∆ 15%)

Targets vs latest close: Bull +62% · Base +25% · Bear -15%

Sentiment & Exposure

Sentiment unavailable: insufficient coverage

Events

Other notable items detected

EVENT2026-05-06
Q4 / FY2025 Earnings Release (assumed)
Expected Q4/FY2025 results may re-rate shares following recent beats; exact date not disclosed in available sources so conservative assumption used (see analyst snippets) and window end chosen for modeling [#SERP-1].
Prob 75.00% • Move 8.00% • Priced-in 50.00%

Short-term Catalysts

Next few weeks

Dividend / cash-return sustainability review
2026-05-06
Market will reassess the high dividend yield and payout sustainability after quarterly cash-flow disclosure; elevated yield already discussed in snippets and may compress if guidance weakens [#SERP-6].
Prob 60% • Move -6% • Priced-in 60%

Long-term Catalysts

Months to a year

Industry capex recovery / long-term E&P activity rebound
2027-02-05
Longer-term ramp in upstream capex would lift demand for Core Labs' specialty well services and reservoir products; assumed multi-quarter recovery toward year+ horizon.
Prob 40% • Move 30% • Priced-in 25%

Risks

Contract pricing pressure on specialized services
Dividend cut or payout suspension
Prolonged E&P capital spending decline

Peers

Symbol	Summary
SLB	Large integrated oilfield services firm; scale and international exposure act as a demand-cycle benchmark for Core Labs.
HAL	Diversified E&P services provider; North American capex sensitivity mirrors CLB's revenue drivers.
BKR	Energy technology and services company; performance tracks offshore and international project pipelines relevant to CLB.
WFRD	Smaller well-services/equipment peer; higher sensitivity to early-cycle recoveries and pricing shifts.

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment AI
Human targets: serper
Targets query: Core Laboratories Inc Common (CLB) analyst consensus price target high low average
Analysis date: 2026-02-05